Page 10 - தாள் கூட்டாளிகள் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from தாள் கூட்டாளிகள் ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In தாள் கூட்டாளிகள் ப்ரோக்ர்யாம் Today - Breaking & Trending Today
The Slaver Waiver in Biden s Amnesty Bill The Slaver Waiver in Biden s Amnesty Bill Punishing those who engage in slavery or human trafficking is an American value March 4, 2021 Andrew R. Arthur In a March 1 post, I noted that there is a Criminal Alien Amnesty Hiding in Biden Amnesty Bill , one that would provide a waiver benefiting drug traffickers, pimps, and rapists (among others). Among the aliens who could get to remain in the United States if this bill passes are those who have been convicted of engaging in slavery and human trafficking. I have been vexed ever since trying to figure out why that bill provides what, in essence, is a slaver s waiver . ....
(2) No royalty payments due for 36 months Planned COVID-related indication in long-hauler patients is the lead focus for crofelemer at Napo EU, the exclusive target of the planned Dragon SPAC, which is pursuing listing on AIM Italia Company expects to provide additional updates regarding Napo EU next week SAN FRANCISCO, CA / ACCESSWIRE / March 5, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced that the Company has entered a binding agreement of terms (the Term Sheet ) for a third non-dilutive royalty financing transaction, pursuant to which Jaguar would sell to the lender for an aggregate purchase price of $5 million (the Royalty Purchase Price ) a royalty interest in future potential crofelemer (Mytesi ....
BioLargo, Inc.: BioLargo Strengthens Balance Sheet by Eliminating Debt as its Commercial Activities Expand WESTMINSTER, CA / ACCESSWIRE / March 2, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced today that it had paid off $650,000 in debt, the bulk of which was scheduled to mature in August of 2021. Other than debt owed by its partially owned subsidiary Clyra Medical, only SBA loans and fixed-price convertible debt remain on BioLargo s balance sheet. Of the SBA loans, management expects all but the $150,000 EIDL 30-year 3.75% APR loan to be forgiven. Of the fixed price convertible debt, $100,000 will convert to equity automatically at the April 20, 2021 maturity date, the $406,000 due in August 2021 may be converted by the investors at a fixed price of $0.14 at any time, and $50,000 is due in two years. ....